GSK Investigational Site

Speyer, Rhineland-Palatinate 67346

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Diabetes Mellitus, Type 2

Studies at this site

• A New Oral Treatment For Type II Diabetes Mellitus — Completed
• Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) — Completed
• Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes — Completed